Direkt zum Inhalt
Merck
  • Extragastrointestinal stromal tumors: Computed tomography and magnetic resonance imaging findings.

Extragastrointestinal stromal tumors: Computed tomography and magnetic resonance imaging findings.

Oncology letters (2014-12-02)
Jingqi Zhu, Zhangwei Yang, Guangyu Tang, Zhongqiu Wang
ZUSAMMENFASSUNG

Extragastrointestinal stromal tumors (EGISTs) are rare mesenchymal tumors that originate outside the gastrointestinal tract. The aim of the present study was to investigate the computed tomography (CT) and magnetic resonance imaging (MRI) features of EGISTs and analyze the correlations between radiological findings and pathological features. CT and MRI images of 24 patients with EGISTs were reviewed retrospectively. Patient demographics and tumor characteristics, including localization, size, contours, borders, cystic-necrotic components, calcification, hemorrhage, tumor vessels, attenuation and intensity, degree and pattern of enhancement, ascites, tumor invasion, lymphadenopathy and distant metastasis were recorded. Statistical analyses to compare the radiological characteristics of low- and high-grade EGISTs were performed with χ

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
N-Methyl-D-Glucamin, 99.0-100.5% (titration)
Sigma-Aldrich
N-Methyl-D-Glucamin, ReagentPlus®, ≥99.0% (T)
Sigma-Aldrich
Meglumin, 99.0-100.5% dry basis, meets USP testing specifications
Supelco
Meglumin, Pharmaceutical Secondary Standard; Certified Reference Material
Meglumin, European Pharmacopoeia (EP) Reference Standard